FDA Grants Rare Pediatric Disease Designation To Quoin's QRX003 For PSS

Quoin Pharmaceuticals received FDA Rare Pediatric Disease Designation for QRX003 in Peeling Skin Syndrome, its second such designation for the candidate. If approved, QRX003 could qualify for a Priority Review Voucher.